Provided By PR Newswire
Last update: Sep 4, 2025
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it is leveraging Lantern Pharma's breakthrough PredictBBB.ai™ platform, a next-generation artificial intelligence (AI) tool with 94% accuracy in predicting blood-brain barrier permeability. This adoption positions Hoth at the forefront of AI-driven drug development, reinforcing its commitment to cutting-edge innovation and accelerated therapeutic discovery.
Read more at prnewswire.comNASDAQ:HOTH (10/1/2025, 11:37:02 AM)
1.63
+0.01 (+0.62%)
Find more stocks in the Stock Screener